Practical Guide,amyloid

The beta amyloid peptide 1-42 human ab120301 is a critical molecule in the study of Alzheimer's disease. This specific peptide, a human variant, plays a central role in the pathological processes associated with this neurodegenerative condition. Understanding its properties and behavior is paramount for researchers aiming to develop effective diagnostic tools and therapeutic interventions.

The beta amyloid peptide (1-42) (human), often abbreviated as Aβ(1-42), is a 42-amino acid fragment derived from the amyloid precursor protein (APP). It is widely recognized as the predominant form of amyloid β-peptide found in the amyloid plaques that accumulate in the brains of individuals with Alzheimer's disease. The aggregation of this peptide into these plaques is a hallmark of the disease and is strongly implicated in neuronal degeneration.

Key Characteristics and Properties:

The beta amyloid peptide 1-42 human has a molecular weight of approximately 4514 g/mol and its molecular formula is C203H311N55O60S. It is a synthetic peptide corresponding to amino acid residues 1 to 42 of the processed human β-amyloid peptide. Researchers often note that Amyloid beta is a highly aggregation prone peptide, which makes it challenging to obtain in a pre-aggregate-free state. This inherent characteristic underscores the importance of careful handling and preparation protocols when working with this peptide.

Several sources offer this peptide for research purposes. For instance, the product with catalog number ab120301 from Abcam is frequently cited in scientific publications and is known to be used in applications such as Mass Spectrometry. Other suppliers, such as CALBIOCHEM, also provide synthetic versions of the beta-Amyloid Peptide (1-42) (human). The purity of these peptides is typically greater than 95%, ensuring reliable experimental results.

Role in Alzheimer's Disease Pathogenesis:

The accumulation of beta-Amyloid (1-42) in the brain is a key event in the pathogenesis of Alzheimer's disease. These amyloid peptides misfold and aggregate, forming oligomers, protofibrils, and eventually the characteristic amyloid plaques. These structures are believed to disrupt synaptic function, trigger inflammatory responses, and ultimately lead to neuronal death. Consequently, beta-Amyloid (1-42) human is considered a significant biomarker of Alzheimer's disease. It can be detected in cerebrospinal fluid (CSF), offering a potential avenue for early diagnosis.

Furthermore, studies have proposed that beta-Amyloid (1-42) is a major component of cerebrovascular amyloid deposits, highlighting its widespread involvement in the pathology of Alzheimer's disease. The human Beta-Amyloid (1-42) fibrils can be used in both in vitro and in vivo studies to investigate the mechanisms of amyloid formation and its toxic effects.

Research Applications and Considerations:

Researchers utilize beta amyloid peptide 1-42 human in various experimental settings. It is employed to investigate rapid oligomer formation and neurotoxicity, crucial aspects of understanding Alzheimer's disease progression. The synthetic peptide corresponding to amino acid residues 1 - 42 allows for controlled experiments to probe the interactions and effects of this peptide.

It is important to note that the human β-Amyloid Peptide (1-42) is distinct from other forms, such as the Human beta-Amyloid Peptide 1-40. The difference in length can influence aggregation properties and biological activity. For control purposes, researchers may use inactive peptides like Amyloid β-peptide (42-1) (human), which is specifically designed to be suitable for use with Beta Amyloid (1-42) Peptide (Human) (ab120301).

The beta amyloid peptide 1-42 human ab120301 is a valuable tool for unraveling the complexities of Alzheimer's disease. Its role in amyloid plaque formation, its detection as a biomarker, and its use in experimental models underscore its significance in the ongoing scientific quest to combat this devastating illness. The availability of high-quality peptides like the beta-Amyloid (1-42), human from reputable suppliers provides the necessary foundation for robust and reliable research.